A b s t r a c t Cutaneous T-cell dyscrasia represents a heterogeneous group of persistent clonal and usually epitheliotropic T-cell infiltrates with a seemingly low risk for progression to mycosis fungoides (MF). Mucin-poor folliculotropic T-cell lymphocytosis is
There exists a spectrum of cutaneous T-cell lymphocytic infiltrates that, based on distinctive clinical, light microscopic, phenotypic, and molecular features, are considered to represent cutaneous T-cell dyscrasias. [1] [2] [3] [4] [5] [6] [7] A clinical and biologic hallmark of this distinctive group of disorders is a risk for disease progression to cutaneous T-cell lymphoma, namely, mycosis fungoides (MF). These disorders represent clonal proliferation of T cells that demonstrate phenotypic aberrations similar to those encountered in MF, although of a more subtle character. Owing to the admixture of reactive CD8 T cells and other regulatory T cells such as CD4+/CD25+ FoxP3 T cells, along with the lower numbers of the atypical lymphocytes, clonality is not always detectable. 1, 3 Among the recognized cutaneous lymphoid dyscrasias are pityriasis lichenoides, 3 pigmented purpuric dermatosis, 4 syringolymphoid hyperplasia with alopecia, 5 alopecia mucinosa, 1 large plaque parapsoriasis, 1 atypical lymphocytic lobular panniculitis, 6 and idiopathic erythroderma. 1, 7 The exact trigger leading to the development of these persistent and often clonally restricted cutaneous T-cell lymphocytic infiltrates is unclear; however, long-term ingestion of immune-dysregulating agents and infectious triggers have been defined as potential risk factors. 4 One phenotypic hallmark of these disorders is the diminished expression of pan-T-cell markers CD7 and CD62L. Although a loss of CD7 and CD62L is emphasized as a phenotypic aberration potentially signifying a T-cell dyscrasia, CD4+/CD7-T cells constitute part of the normal T-cell repertoire and may be expanded in certain conditions without signifying lymphoma. [8] [9] [10] [11] [12] Selective expansion of CD4+/CD7-lymphocytes has been observed in select immune dysregulatory states, namely, HIV infection, autoimmune disease such as rheumatoid arthritis, and druginduced lymphomatoid reactions and following bone marrow Upon completion of this activity you will be able to:
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and renal transplantation. [8] [9] [10] [11] [12] Antigenically responsive T-cells, especially those which preferentially accumulate in the skin, may exhibit diminished CD7 expression. The normal biology of CD62L expression includes the maintenance of expression of L-selectin in non-neoplastic memory T-cells including those which home to the skin. There is a normal subpopulation of memory T-cells which are CD62L negative, but this population of cells is uncommonly found in the skin. Most characteristically CD62L+ lymphocytes accumulate in the skin although this population may subsequently exhibit a loss of CD7 as part of the clonal response to antigen stimulation. 12 In general, the reduced expression of CD7 and CD62L in reactive states is of lesser magnitude than that noted with the lymphoid dyscrasias and lymphoma. 12 Among the differences between cutaneous lymphoid dyscrasia and autoimmune disease is the directed nature of the clonally restricted T cells responding to self-epitope in the setting of autoimmune disease. In contrast, the lymphocytic infiltrates that define cutaneous lymphoid dyscrasias and cutaneous T-cell lymphoma are without a defined antigen-responsive T-cell clonal expansion. In the cutaneous lymphoid dyscrasias, the counterregulatory mechanisms that control and limit clonal T-cell expansion seem to prevent progression to lymphoma in the majority of patients, although the regulatory T-cell populations (ie, Fox P3 and cytotoxic CD8 lymphocytes) are nevertheless insufficient to permanently eradicate the clones.
This article describes a series of patients with a distinct form of cutaneous lymphoid dyscrasia that, to date, has received little attention, ie, folliculotropic T-cell lymphocytosis, that is distinct from alopecia mucinosis by virtue of the lack of intrafollicular mucin deposition. In a recent review, such cases were designated as pilotropic T-cell dyscrasia. 1 This entity was first described by Kossard and Rubel 13 as folliculotropic T-cell lymphocytosis. There are 3 prior cases reported in the literature [13] [14] [15] that describe folliculotropic T-cell lymphocytosis. In the current series, we describe the clinical and pathologic findings in 24 cases of folliculotropic T-cell lymphocytosis, emphasizing its place among the cutaneous lymphoid dyscrasias.
Materials and Methods
By using a natural language search, we obtained cases of folliculotropic T-cell lymphocytosis from the Weill Cornell (New York, NY) dermatopathology database during the period July 1, 2006, to November 20, 2009 . The cases included 2 cases sent in consultation and 21 cases submitted to the routine dermatopathology practice. One case was encountered prospectively at Regional Medical Laboratory, Tulsa, OK. Skin biopsy specimens in all cases had been submitted for routine diagnostic assessment. In each case, routine light microscopic analysis and phenotypic and molecular studies were conducted on paraffin-embedded, formalin-fixed tissue. The comprehensive phenotypic panel included antibodies to β F1, CD2, CD3, CD4, CD5, CD7, CD62L, and CD8. A standard T-cell receptor γ gene rearrangement assay was performed. These immunohistochemical and molecular methods have been previously reported. 4 This study received institutional review board approval under protocol number 0710009479 from Weill Medical College of Cornell University, New York, NY. 
Results

Clinical Features
There were 12 males and 12 females, ranging in age from 7 to 68 years (mean and median, 44 years) ❚Table 1❚. Of the patients, 11 were 40 years or younger, including 2 who were younger than 20 years. In 15 of the cases, the clinical requisition suggested a form of lymphoproliferative disease in the context of MF or pseudolymphoma. It was clinically thought to be folliculocentric in 10 of the cases based on the question of folliculitis and the observation of comedones and/or alopecia. In 12 cases the disease, although persistent, improved with potent topical and intralesional steroids, narrow-band ultraviolet light therapy, interferon alfa, and/or sunlight. In the cases in which the lesions underwent complete resolution with topical steroid therapy, the lesions recurred when the steroids were stopped. In 3 cases, the lesions resolved without recurrence.
In 9 cases when the referring dermatologist was contacted to obtain subsequent patient follow-up, the patient had not returned; no further information about the clinical course was available.
In 1 case in which the lesions were present for 5 years, a subsequent biopsy was confirmatory of follicular MF; the patient reported a progression in the size and number of lesions in the year preceding the development of MF.
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❚Image 1❚ A, A 47-year-old man had a 3 -year history of follicular-based indurated papules on the cheeks that have followed a waxing and waning course. The lesions respond initially to topical steroids and then return. B, The biopsy specimen shows a prominent infiltrate in the adventitial dermis. There is prominent infiltration of the outer root sheath epithelium by lymphocytes (×40). C, The cells permeating the outer root sheath epithelium have a small cerebriform appearance. Note the absence of other cellular elements (×100). D, The CD3 stain highlights the extent of the perifollicular and folliculotropic lymphocytic infiltrate (×20).
especially eosinophils, were noted; the infiltrate extended to involve the lower portion of the hair follicle along with extensive interfollicular dermal involvement.
Phenotypic Studies
In all cases, the infiltrating lymphocytes expressed β F1, CD2, CD3, and CD5 ❚Table 2❚. There was a notable striking increase in the CD4/CD8 ratio in excess of 5:1. A consistent finding seen in virtually all of the cases was a substantial reduction in CD62L whereby less than 30% of the infiltrate was positive in 11 cases ❚Image 1F❚. There was consistently a greater reduction of CD7 expression in lymphocytes infiltrating the follicular epithelium compared with the surrounding adventitial dermis or around vessels ❚Image 1E❚ and ❚Image 2C❚. In 11 cases, CD7 was expressed by 50% or fewer of the intrafollicular lymphocytes, even if there was relative preservation of CD7 expression in dermal lymphocytes. In 6 cases there was no significant reduction in CD7 expression. In the 1 case in which there was progression to MF, there were a number of transformed CD30+ lymphocytes in zones of interfollicular dermal infiltration. A CD1a stain showed striking intrafollicular LC hyperplasia in the infundibulum and more superficial aspects of the follicle, corresponding to the areas of follicular infiltration by lymphocytes.
Molecular Studies
In 5 cases, a monoclonal T-cell population was detected; in 15 cases a polyclonal result was obtained ❚Image 3❚. In the remaining cases, there was insufficient DNA, precluding assessment.
The duration of the lesions ranged from 3 months to 13 years (mean duration, 3.5 years). In 17 patients, a drug history was obtained. Patients were taking certain medications 1 year or more before lesional development in 11 of the 17 cases. Among the classes of drugs were statins (4 cases), antidepressants (2 cases), antihistamines (2 cases), angiotensinconverting enzyme inhibitors (2 cases), and benzodiazepines, a proton-pump inhibitor, fenofibrate, and an antiseizure drug in 1 patient each.
Routine Light Microscopy
All cases shared a folliculotropic lymphocytic infiltrate with pronounced interfollicular and/or eccrinotropic lymphocytosis. The follicular infiltration characteristically involved the infundibulum and superficial to mid isthmus region of the follicle ❚Image 1B❚. There was no differential atypia between the lymphocytes in the adventitial dermis and follicular epithelium. The cytomorphology was dominated by small, mature lymphocytes. Cytologic atypia was discernible under 100× objective magnification, whereby cells had cerebriform morphologic features typical of a small Lutzner cell ❚Image 1C❚. Lymphocytes were found in close apposition to Langerhans cells (LCs) within the follicular epithelium. There was no accompanying follicular mucinosis. There was a noticeable absence of other inflammatory cells, ie, eosinophils and plasma cells. Infiltration of the adventitial dermis was a common finding. In many cases, the density of infiltration was low, accompanied by follicular hyperkeratosis rather than perifollicular fibrosis and/ or follicular epithelial destruction ❚Image 2B❚. In the 1 case in which there was progression to MF, other inflammatory cells,
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E, The CD7 preparation shows a substantial reduction in the expression of this marker amidst the lymphocytes (×20). F, Compared with the extent of reduction noted for CD7 illustrated in C, there is a much greater decrement in the degree of CD62L expression (×20).
Discussion
We describe the clinical and pathologic features of 24 patients with a distinctive form of cutaneous lymphoid dyscrasia designated folliculotropic T-cell lymphocytosis. In all cases, there was migration of mildly atypical lymphocytes into the outer root sheath epithelium of the hair follicle unaccompanied by significant mucinosis and/or epithelial injury. There were accompanying phenotypic aberrations analogous to those observed in other forms of cutaneous lymphoid dyscrasia, including reproducible losses in the expression of CD7 and CD62L. The average age at diagnosis was younger than that for MF. As with other types of cutaneous lymphoid dyscrasia, there was no sex predilection. In the patients for whom follow-up was available, all patients, excluding 1 in whom the disease progressed to MF, the cutaneous eruption was largely nonprogressive, demonstrating a fairly rapid treatment response with conservative measures such as light therapy or topical steroids, at least in the time of follow-up (3.5 years).
The term folliculotropic T-cell lymphocytosis was introduced by Kossard and Rubel, 13 who described a patient with clinical manifestations similar to those noted in several of our cases. The cases presented herein represent a unique form of T-cell dyscrasia with morphologic, phenotypic, and molecular hallmarks that comprise mildly atypical CD4+ T-cell folliculotropic infiltrates, typically of low density, unaccompanied by other inflammatory cell infiltrates or mucin. Clonality may be seen, and a decrease in the expression of CD7 and CD62L is frequent. The cases lack morphologic criteria to warrant designation as follicular MF.
The pilotropic cutaneous T-cell dyscrasias include follicular MF, [16] [17] [18] alopecia mucinosis, 19, 20 and folliculotropic T-cell lymphocytosis. [13] [14] [15] Although the terms idiopathic follicular mucinosis and alopecia mucinosis have been used synonymously, as any inflammatory condition affecting the follicle can be associated with follicular mucinosis, the diagnosis of idiopathic follicular mucinosis and/or alopecia There is attendant thinning of the follicular epithelium (×10). C, There is a marked reduction in the extent of staining for CD7 compared with CD3 (CD7 illustrated, ×40).
mucinosis is one that must be correlated with the clinical manifestations and other aspects of the histopathologic features. The basis for categorizing the cases presented in this series as a form of pilotropic T-cell dyscrasia includes the persistent nature of the eruption, including recurrence despite treatment, the lack of a clear antigenic trigger, the presence of lymphoid atypia from cytomorphologic and phenotypic perspectives, and the presence of clonality. 1 One patient in this series exhibited a progressive clinical course eventuating in MF. [13] [14] [15] A risk of progression to lymphoma is inherent in prelymphomatous dyscrasias, whether in the context of this entity or other conditions such as atypical lymphocytic lobular panniculitis, pityriasis lichenoides, or pigmented purpuric dermatosis. 1 The phenotypic abnormalities observed in folliculotropic T-cell lymphocytosis comprise reductions in CD62L and CD7 expression and a high CD4/CD8 ratio in the intrafollicular lymphocytes.
There appeared to be a disparity between the striking reduction of CD62L expression and the lesser extent of reduction noted for CD7. While it was uncommon to see more than 20% of the infiltrate exhibiting CD62L expression, the CD7 reduction could be minimal (ie, <30%). The sensitivity of CD62L loss as a feature of this form of cutaneous lymphoid dyscrasia is of interest. A greater degree of preservation of CD7 compared with CD62L expression defines a profile different aggressive clinical course compared with classic MF; the reduction in survival is more apparent at 10 to 15 years from the initial diagnosis. 17 Patients with early limited manifestations of follicular MF may respond to select skin-directed therapies including psoralen plus ultraviolet A and narrow-band UV-B, nitrogen mustard, and bexarotene gel. 17 In folliculotropic T-cell lymphocytosis, there is confinement of the lymphocytes to the superficial isthmus and follicular infundibulum, possibly reflecting intrafollicular localization of LCs to this portion of the follicle. Specifically, it has been shown that LCs were most concentrated in the infundibulum and superficial isthmic portion of the follicle with extension into the germinative sebaceous epithelium. 32 In follicular MF, 1 hallmark is extensive and striking infiltration of the lower portion of the follicle; the proliferation is apparently independent of follicular LCs, which implies selection of autonomous T-cell clones with a biologic profile different from those in folliculotropic T-cell lymphocytosis, potentially explaining the aggressive nature of follicular MF. 33 There are 3 other reported cases of folliculotropic T-cell lymphocytosis. 13 In the index case reported by Kossard and Rubel, 13 multiple patches of hair loss associated with follicular keratotic plugs were identified. Owing to lack of greater cytologic atypia, the authors could not designate the lesions as representing MF. van de Kerkhof et al 15 reported a case with follicular hyperkeratosis and cysts and mild infiltration of the outer root sheath epithelium by lymphocytes. During a period of several years, the patient's skin condition eventuated in follicular MF. One patient had a 4-year history of patches of hair loss associated with follicular keratotic plugs 13 ; a subsequent biopsy from the right leg was held to reflect progression to MF.
The role of immune-dysregulating drugs in the evolution of the cutaneous lymphoid dyscrasias is a topic discussed in an earlier article addressing pigmented purpuric dermatosis 4 ; we found that a significant percentage of patients had been receiving antidepressant therapy on a long-term basis. In the current series, in roughly half of the cases, we were able to elicit a drug history, ie, ingestion of drugs associated with reversible T-cell dyscrasia largely confined to select drug classes, including the benzodiazepines, antihistamines, antidepressants, and statins. Lymphomatoid folliculitis as a form of drug-induced pseudolymphoma was reported previously. 34, 35 Folliculotropic T-cell lymphocytosis is a distinctive form of cutaneous lymphoid dyscrasia with characteristic clinical manifestations and histopathologic features. It is part of the clinical and morphologic spectrum of the prelymphomatous dyscrasias. In most cases, the clinical course is indolent, but as with the other forms of cutaneous lymphoid dyscrasia, there is an inherent, apparently small risk of progression to MF. Immune-dysregulatory drug therapy should be addressed as a potential factor in its evolution. from most cases of MF in which both markers are reduced significantly and often to the same extent. It should be emphasized that reductions in these 2 markers is not pathognomonic of T-cell dyscrasia as there may be selective expansion of cells that exhibit variable losses of CD7 and CD62L in states of altered immunity such as autoimmune disease. Based on previously published work, reductions in CD7 and CD62L are seen in various nonneoplastic inflammatory states; however, the extent of reduction seen in the cases of folliculotropic T-cell lymphocytosis is not observed. 12 In particular, the reduction of CD7 expression can be in the 20% to 40% range, while in this study, the extent of reduction of CD62L in reactive inflammatory states was not as striking as that of CD7. The converse was true in folliculotropic T-cell lymphocytosis and other related T-cell dyscrasias in which the extent of reduction of CD62L is frequently substantial and often exceeds that noted for CD7. 12 A further confounding factor in these cases is the lack of clonality when using a routine polymerase chain reaction-based method to detect T-cell receptor γ gene rearrangement. In the prelymphomatous dyscrasias, many of the infiltrating cells are reactive 1 ; in concert with the low density of the infiltrates, this likely accounts for the detection of polyclonal populations in many of these cases. The aberrant clone is likely among the many different smaller clones of reactive T cells. The clone may expand sufficiently to become detectable by conventional polymerase chain reaction studies. A superior method to detect an emerging T-cell clone 2 in a polyclonal background is BioMed fragment size gel electrophoresis. 21 Even cases showing an apparent polyclonal background may harbor a more dominant clone that emerges in later biopsies as a true monoclonal T-cell population. 3 The distinction from follicular MF can be difficult, but there are reproducible clues: greater degrees of cytologic atypia, density, and depth of infiltration and reduction of CD7 expression. In follicular MF, many of the infiltrating cells are intermediate sized to large as opposed to the small cells that typify folliculotropic T-cell lymphocytosis. The background population is polymorphous in follicular MF with tissue eosinophilia, neutrophilia, and granulomatous foci. The depth of infiltration needs to be emphasized, 18, [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] as in follicular MF the infiltrates are deeper-seated and surround and permeate the follicle below the entry of the sebaceous gland, often with syringotropism and distinct follicular epithelial hyperplasia. 29 Monoclonality is more commonly observed in follicular MF compared with folliculotropic T-cell lymphocytosis, and the clinical manifestations of follicular MF can be dramatic, ie, as boggy infiltrative plaques and nodules devoid of hair with comedone-like hyperkeratotic follicular lesions. 28 In more than 80% of patients, a head and neck predilection, especially involving the eyebrows, is characteristic. 28 Truncal involvement in concert with head and neck lesions is more common than disease isolated to the head and neck area. 17 Studies have suggested that the follicular variant of MF follows a more
